News & Analysis on Clinical Trial Services & Contract Research And Development
Tecan has launched the Freedom EVO 96R and EVO 384R, two new integrated multi-channel pipetting platforms for liquid handling applications. These systems will be presented at the "Drug Discovery Technology" exhibition in Boston, USA from August 8-13.
Last week's International Conference on AIDS in Thailand was marked by a report that pointed to a dearth of innovation in HIV vaccine research, both from the manufacturing perspective and in terms of the mechanism of action of clinical candidates.
Belgian pharmaceutical and chemicals company UCB, fresh from its €2.25 billion acquisition of UK biotech Celltech, has divested its films business in a move that takes it another step closer to becoming a biopharmaceutical pure-play.
Chiral Quest has forged an alliance with DSM to accelerate the take-up of its catalysis products, used in the synthesis of chemicals and pharmaceuticals.
In the first study of its kind, researchers have identified the genes in non-cancerous supporting cells that can encourage the growth of breast cancer cells. The findings suggest aiming chemotherapy at both normal and cancer cells might improve breast...
Drug discovery company Ablynx is to enter into a partnership with Proctor and Gamble Pharmaceuticals. The agreement will make use of Ablynx's Nanobody platform to develop drug candidates against a G-protein coupled receptor (GPCR) target specified by...